Tscan Therapeutics, Inc. · NASDAQ:TCRX
Readout Capital, LP reported a 5.40% stake in Tscan Therapeutics, Inc. (Schedule 13G)
Event Sep 21, 2026 · Filed Sep 25, 2026
Readout Capital, LP reported a 5.40% stake in Tscan Therapeutics, Inc., 3,453,388 shares, as a passive investor on Sep 21, 2026. Filed Sep 25, 2026 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 3,453,388
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Readout Capital, LP | 5.40% | 3,453,388 |
| Readout Capital GP, LLC | 5.40% | 3,453,388 |
| Matthew Smith | 5.40% | 3,453,388 |
Source
Related
- Tscan Therapeutics, Inc.
- Readout Capital, LP
- Tscan Therapeutics, Inc. shareholders
- Form 4 · MacBeath Gavin · Oct 2, 2026
- Form 4 · Zdraveski Zoran · Oct 2, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · May 15, 2026